MELANOMA TREATMENTS

摘要

The disclosure provides methods for treating melanoma with an improving therapeutic effectiveness of drugs and reducing drug toxicity. Specifically, the disclosure provides personalized treatments of melanoma that optimize the therapeutic effect of a drug based on identifying the presence, absence or amount of a biomarker in a subject having the melanoma to whom an anti-cancer drug has been administered. Further disclosed are microRNA biomarkers that can be used for optimizing therapeutic efficacy of treating melanoma in a subject.